5C Network, an online medical diagnostic platform, recently raised a $4.6 million Series A round led by deep tech venture capital firm Celesta Capital, with existing investors Unitus Ventures and Axilor Ventures and angels including Ajay Gupta McKinsey & Company Emeritus Partner Investors involved, Rohit Razdan and Shiv Tallam, said in a statement.

Medical diagnostics is an $11 billion market in India with an annual growth rate of 16%. 5C has been working to transform the entire diagnostic experience for patients — from scheduling tests to getting accurate and timely digital reports, with an average TAT of 39 minutes and an accuracy rate of over 99.3%, the statement said.

“5C Network is one of the pioneers in the development of digital diagnostics in healthcare,” said Kalyan Sivasailam, CEO of 5C Network. “By enabling comprehensive, seamless test bookings for the clinical delivery experience, we believe we will transform the way every stakeholder in the healthcare ecosystem experiences diagnostics.”

The raise comes on the heels of Tata 1 mg’s strategic investment in 5C Network. “The Indian healthcare system needs digital and point-of-care devices to help clinical networks manage cost, turnaround time and clinical quality,” said Sudhir Rao, managing partner at Celesta Capital. “5C network has hyper-locally connected CT, MRI and X-ray machines can manage the workflow of patients, clinical networks and hospitals, and can now rely on AI and ML to improve clinical outcomes for pathologists and radiologists.”